Cbd Global Sciences Inc (CBDN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 66 | 160 | 301 |
| Income taxes - deferred | N/A | N/A | -116 |
| Accounts receivable | 13 | 297 | -283 |
| Accounts payable and accrued liabilities | 676 | N/A | N/A |
| Other Working Capital | 909 | 658 | 1,160 |
| Other Operating Activity | -2,802 | -2,455 | -2,999 |
| Operating Cash Flow | $-1,139 | $-1,340 | $-1,937 |
| Cash Flows From Investing Activities | |||
| PPE Investments | 77 | 55 | -210 |
| Net Acquisitions | 144 | N/A | N/A |
| Investing Cash Flow | $221 | $55 | $-210 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | N/A | 250 |
| Debt Issued | 1,054 | 1,241 | 1,014 |
| Debt Repayment | -233 | -254 | -799 |
| Common Stock Issued | 55 | 113 | 1,386 |
| Other Financing Activity | 135 | 165 | -2 |
| Financing Cash Flow | $1,011 | $1,263 | $1,849 |
| Beginning Cash Position | 1 | 22 | 320 |
| End Cash Position | 93 | 1 | 22 |
| Net Cash Flow | $93 | $-21 | $-299 |
| Free Cash Flow | |||
| Operating Cash Flow | -1,139 | -1,340 | -1,937 |
| Capital Expenditure | -3 | N/A | -210 |
| Free Cash Flow | -1,142 | -1,340 | -2,148 |